Cite
HARVARD Citation
Lund, J. et al. (2018). Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma. MAbs. 10 (1), pp. 118-128. [Online].